Rare Inflammatory Disease Treatment Market

The rare inflammatory disease treatment market is projected to grow from USD 15.2 billion in 2025 to USD 23.8 billion by 2035, at a CAGR of 4.6%. RID Treatment for Ulcerative Colitis will dominate with a 38.2% market share, while biologics-based rid treatment will lead the drug class segment with a 52.7% share.